EXPERIMENTAL LUNG RESEARCH

Scope & Guideline

Innovating Approaches to Respiratory Health

Introduction

Immerse yourself in the scholarly insights of EXPERIMENTAL LUNG RESEARCH with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0190-2148
PublisherTAYLOR & FRANCIS INC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1980 to 2024
AbbreviationEXP LUNG RES / Exp. Lung Res.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal 'EXPERIMENTAL LUNG RESEARCH' is dedicated to advancing the understanding of lung biology, pathology, and treatment methodologies. Its primary focus lies in experimental studies that uncover novel insights into lung diseases and therapeutic strategies.
  1. Lung Pathophysiology:
    Research aimed at understanding the mechanisms underlying various lung diseases, including acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and lung cancer.
  2. Inflammatory Responses:
    Studies focusing on the role of inflammation in lung diseases, including the investigation of cytokines, immune cell responses, and signaling pathways involved in lung injury and repair.
  3. Therapeutic Interventions:
    Exploration of innovative treatments and therapeutic approaches for lung diseases, including pharmacological therapies, gene therapies, and the use of biologics.
  4. Microbiome and Environmental Factors:
    Research examining the influence of the lung microbiome and environmental exposures (e.g., pollutants, allergens) on lung health and disease progression.
  5. Cellular and Molecular Mechanisms:
    Investigations into the cellular and molecular mechanisms contributing to lung pathology, including apoptosis, autophagy, and extracellular matrix remodeling.
The journal has also witnessed a rise in certain themes that reflect current trends in lung research, particularly those that align with advancements in technology and an increased understanding of complex biological processes.
  1. Exosomal and MicroRNA Research:
    There is a notable increase in studies exploring the role of exosomes and microRNAs in lung diseases, highlighting their potential as biomarkers and therapeutic targets.
  2. Role of the Immune System in Lung Disease:
    Recent publications emphasize the immune system's contribution to lung pathology, including the interplay between various immune cell types and their signaling pathways in inflammatory responses.
  3. Targeted Therapeutics and Personalized Medicine:
    An emerging focus on targeted therapies and personalized medicine approaches for treating lung diseases reflects a shift towards more individualized treatment strategies.
  4. Impact of Environmental Exposures:
    Growing interest in understanding how environmental factors, such as air pollution and smoking, influence lung health and disease progression is evident in recent research.
  5. Molecular Mechanisms of Disease:
    Increased exploration of specific molecular pathways, such as autophagy and pyroptosis, indicates a trend towards elucidating detailed mechanisms that could inform targeted interventions.

Declining or Waning

While 'EXPERIMENTAL LUNG RESEARCH' has a rich history of diverse topics, certain themes have shown signs of declining interest in recent publications. This could reflect shifts in research focus or advancements that have rendered some areas less critical.
  1. Basic Mechanisms of Lung Development:
    Research centered on the fundamental biology of lung development has become less frequent, possibly due to a shift towards more clinically relevant studies and translational research.
  2. Traditional Animal Models:
    While animal models remain important, there appears to be a waning emphasis on traditional models in favor of more innovative approaches, such as organoids or humanized models that better mimic human lung responses.
  3. Single-Agent Pharmacology:
    Studies focusing solely on the effects of single pharmacological agents are declining, as there is a growing interest in combination therapies and personalized medicine approaches.

Similar Journals

THORAX

Illuminating the path in pulmonary and respiratory studies.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Respiratory Investigation

Elevating research for better respiratory care.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

Egyptian Journal of Chest Diseases and Tuberculosis

Transforming knowledge into practice for better respiratory care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

EUROPEAN RESPIRATORY JOURNAL

Elevating Knowledge in Pulmonary Medicine
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Jornal Brasileiro de Pneumologia

Empowering professionals through vital pulmonary research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Respiratory Medicine and Research

Connecting research to real-world respiratory solutions.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Respiratory Medicine and Research, published by Elsevier, is a pivotal journal in the field of Pulmonary and Respiratory Medicine, dedicated to advancing the understanding and treatment of respiratory diseases. Since its inception in 2019, the journal has provided a platform for high-quality research, contributing significantly to the scientific community's knowledge base, as reflected in its impressive Q2 categorization in 2023. With a Scopus rank of #94 out of 155, placing it in the 39th percentile, this journal is essential for researchers, professionals, and students seeking the latest advancements in respiratory medicine. Although currently categorized as a non-open access publication, it remains accessible to those affiliated with institutions with subscriptions. Published in France, the journal aims to foster collaboration and innovation by highlighting original research, clinical studies, and comprehensive reviews that address pressing issues in respiratory health.

LUNG

Exploring the complexities of lung diseases for better patient outcomes.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

RESPIROLOGY

Pioneering Research for a Breath of Fresh Air
Publisher: WILEYISSN: 1323-7799Frequency: 12 issues/year

RESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.

Current Pulmonology Reports

Exploring the latest innovations in pulmonology.
Publisher: SPRINGERISSN: Frequency: 4 issues/year

Current Pulmonology Reports, published by SPRINGER, stands as a vital resource in the realm of respiratory health, delivering peer-reviewed research that informs clinical practices and advances understanding within the field of pulmonology. With an E-ISSN of 2199-2428, this journal captures the latest findings and technological innovations pertinent to respiratory diseases, treatment protocols, and patient management strategies. Although currently classified as non-open access, it ensures robust dissemination of significant research contributions which are essential for professionals and scholars alike. The journal's objective is not only to foster a deeper understanding of lung health issues but also to bridge the gap between research and application, thereby impacting real-world practices. As the demand for comprehensive studies in pulmonology continues to grow, Current Pulmonology Reports seeks to maintain its position as a premier outlet for quality research, ultimately bettering outcomes in respiratory medicine.

Zeitschrift fur Pneumologie

Catalyzing Change in Pulmonary Health Research
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.